TP53 and renal cell carcinoma: Angiopoietin-like protein 3 can bind to focal adhesion kinase and inhibit its nuclear translocation induced by sorafenib, attenuating p53 ubiquitination overexpression, enhancing the sensitivity of RCC cells to sorafenib and contributing to cellular apoptosis [81].